|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 17653 |
FusionGeneSummary for IPPK_VTI1B |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: IPPK_VTI1B | Fusion gene ID: 17653 | Hgene | Tgene | Gene symbol | IPPK | VTI1B | Gene ID | 64768 | 10490 |
| Gene name | inositol-pentakisphosphate 2-kinase | vesicle transport through interaction with t-SNAREs 1B | |
| Synonyms | C9orf12|INSP5K2|IP5K|IPK1|bA476B13.1 | VTI1|VTI1-LIKE|VTI1L|VTI2|v-SNARE|vti1-rp1 | |
| Cytomap | 9q22.31 | 14q24.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | inositol-pentakisphosphate 2-kinaseIPK1 homologbA476B13.1 (novel protein)inositol 1,3,4,5,6-pentakisphosphate 2-kinaseins(1,3,4,5,6)P5 2-kinaseinsP5 2-kinase | vesicle transport through interaction with t-SNAREs homolog 1Bvesicle transport v-SNARE protein Vti1-like 1vesicle-associated soluble NSF attachment protein receptor | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q9H8X2 | Q9UEU0 | |
| Ensembl transtripts involved in fusion gene | ENST00000287996, ENST00000486841, ENST00000375522, | ENST00000554659, | |
| Fusion gene scores | * DoF score | 6 X 3 X 6=108 | 5 X 5 X 3=75 |
| # samples | 7 | 5 | |
| ** MAII score | log2(7/108*10)=-0.625604485218502 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: IPPK [Title/Abstract] AND VTI1B [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | IPPK | GO:0052746 | inositol phosphorylation | 12084730 |
| Tgene | VTI1B | GO:1903076 | regulation of protein localization to plasma membrane | 18570918 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | HNSC | TCGA-CV-7446-01A | IPPK | chr9 | 95418738 | - | VTI1B | chr14 | 68118198 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000287996 | ENST00000554659 | IPPK | chr9 | 95418738 | - | VTI1B | chr14 | 68118198 | - |
| intron-3CDS | ENST00000486841 | ENST00000554659 | IPPK | chr9 | 95418738 | - | VTI1B | chr14 | 68118198 | - |
| intron-3CDS | ENST00000375522 | ENST00000554659 | IPPK | chr9 | 95418738 | - | VTI1B | chr14 | 68118198 | - |
Top |
FusionProtFeatures for IPPK_VTI1B |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| IPPK | VTI1B |
| Phosphorylates Ins(1,3,4,5,6)P5 at position 2 to formIns(1,2,3,4,5,6)P6 (InsP6 or phytate). InsP6 is involved in manyprocesses such as mRNA export, non-homologous end-joining,endocytosis, ion channel regulation. It also protects cells fromTNF-alpha-induced apoptosis. {ECO:0000269|PubMed:12084730,ECO:0000269|PubMed:15967797}. | V-SNARE that mediates vesicle transport pathways throughinteractions with t-SNAREs on the target membrane. Theseinteractions are proposed to mediate aspects of the specificity ofvesicle trafficking and to promote fusion of the lipid bilayers.May be concerned with increased secretion of cytokines associatedwith cellular senescence. {ECO:0000269|PubMed:23217709}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for IPPK_VTI1B |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for IPPK_VTI1B |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| IPPK | CDK12, LPAR1, TYRO3, ENPP4, SELT, SLC9A1, SC5D, CERS4, CERS5, ATP2B3, TMEM87B, GPR50, CPLX4, ZDHHC17, ATP9A, ARL6IP1, ZDHHC18, COLEC12, ATP2B4, TESC, GPR137, GPRC5B, TMEM186, SNX13, LEMD3, CD97, SNX14, NDUFAF1, ECSIT, ADCY6, GOLGA5, FAM134C, CKAP4, SCAP, C4orf32, RTN2, FZD8, TMEM11, TMEM87A, RMND1, STX4, SERINC1, TMEM161B, ND2, CXCR4, CERS6, LMBR1, NDC1, STX8, MPZL1, SLC30A5, SLC7A3, TMEM223, REEP6, ZDHHC9, YIPF4, KIAA1715, FAM20B, SMAD5, FITM2, EXTL2, ARL10, OCIAD1, C10orf35, CSGALNACT2, EXTL3, PIGW, ITPR2, MBOAT7, GPRC5C, ACP2, VEZT, MRS2, STXBP3, MFSD8, PTPLB, GP1BB, KTN1, LPCAT3, LGALS3, VAMP3, GOLGB1, CD47, LRRC8A, PCDH19, KDSR, DAGLB, TSPAN15, GPR89A, TMEM63B, LPHN3, ARV1, LCLAT1, ZDHHC13, ACAD9, CERS2, GPR108, TTYH3 | VTI1B | STX8, STX5, VAMP4, STX7, NSF, ATP6V1B1, STX4, PTPN5, SYNE4, TRIM59, KRTAP10-7, LDLRAD1, CAND2, EIF2B5, RNF13, EIF2B1, CCDC9, EIF2B4, IPO7, NAPA, IPO9, STX18, EIF4A3, NBAS, NAPG, CWC27, CWC22, STX6, HEPHL1, CALML3, ACIN1, ECD, AP3B1, S100A3, STX12, AP3M1, VPS45, SESTD1, PPP1R15B, UBTF, EIF2B2, STXBP5, EIF2B3, VSIG8, DSG4, FHL2, ARL10, STX10, VAMP3, CASC3, ACP2, C19orf25, PPP2R5E, CLEC12A, CEP170, TNFSF13B, HAUS7, SLC39A4, DTNBP1, EVA1C, CREB3, CLTC, GTSE1, DUSP22, MED21, CLINT1, GDPD5, AP1S2, STXBP6, TRDN, SCN3B, STAMBPL1, SEC22B, STX11, HAUS1, RABGEF1, CDH5, ASPH, TBC1D15, PRPSAP2, STAMBP, MANSC1, EXOC1, DCTN2, LMNA |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for IPPK_VTI1B |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for IPPK_VTI1B |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|